Skip to content
Sample Page
Author:
BioNexus Gene Lab Corp.
Posted Date:
May 29, 2026
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
BioNexus Gene Lab Corp.
May 29, 2026
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
BioNexus Gene Lab Corp.
March 11, 2026
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
BioNexus Gene Lab Corp.
February 23, 2026
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
BioNexus Gene Lab Corp.
January 28, 2026
